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 Bakuchiol is a monoterpinoid compound found mainly in the seeds of Psoralea 
coryfolia Linn, which is indigenous to Southeast Asia. Since its discovery and isolation in 
1967, it has been reported to contain a multitude of health benefits. It exhibits antitumor, 
antidiabetic, antimicrobial and recently discovered anti-aging properties. There are 
multiple ways in which bakuchiol has been synthesized. Research herein used the 
lactonization of an achiral hydroxydiester as the key step in a series of small molecule 
manipulations which formed compounds for the future synthesis of bakuchiol. The goal 
described in this thesis was to create a new synthetic pathway for bakuchiol. The steps 
included two lactonizations, two ring openings, two protections and subsequent 
deprotections of alcohol groups, a Horner-Wadsworth-Emmons, and a Grignard reaction. 
These steps built upon the all carbon quaternary center, which can be installed using the 
desymmetrization method developed by the Petersen lab, and were used to manipulate 
the molecule to form the desired bakuchiol precursors. Herein is presented the efforts and 
methodology developed towards the total synthesis of bakuchiol via small molecule 
manipulation upon a quaternary center. This pathway may also be of use for the 
development of various analogs of bakuchiol which may have various medicinal 
properties. 
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CHAPTER I 
 
INTRODUCTION TO BAKUCHIOL AND DESYMETRIZATION 
 
 
1.1 Description 
 Bakuchiol (1), also know as 4-(3-ethenyl-3,7-dimethyl-1,6-octadienyl) phenol, is 
a phenolic monoterpinoid compound with one chiral center and is the major component 
of the seeds of Psoralea coryfolia L.1 The plant is a common herbaceous weed found 
along road sides and in fields in China, India, Burma and Pakistan. It is an annual herb 
with grooved and gland dotted stems and branches.2 The leaves are simple green with a 
broad and elliptically rounded shaped. They are speckled with small black dots and 
covered with fine white hairs on both sides. The flowers can be a blue purple color or 
yellow. The fruits of the plant are small, compressed, and pitted in appearance. They are 
used in traditional folk medicine as a laxative, and for the treatment of leprosy, psoriasis 
and inflammatory diseases of the skin.3,4 The seeds are where bakuchiol is found. They 
are black and brown with a flat oblong shape.5 The molecule was named after the 
Sanskrit name (Bakuchi) of the plant. Bakuchiol is a clear colorless liquid. It is soluble in 
hexane and insoluble in 10 % aqueous NaOH.6 Figure 1 shows the molecular structure of  
(+)-bakuchiol.
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Figure 1. (+)- Bakuchiol 
 
 
Since the first discovery of bakuchiol in 1966, it has been found to occur naturally 
in other plants, such as the leaves of P. grandulosa in 1996,7 Ottholobium pubescens in 
1999,8 P. drupaceae in 2010,9 Ulmus davidiana in 2010,10 and Piper longum in 2010.11  
1.2 Medicinal Properties 
 Bakuchiol has been used in traditional Indian and Chinese medicine to treat a 
variety of diseases. In 1992, Rangari et. al. discovered that bakuchiol has cytotoxic 
activity and this has been a main point of study since.12 In a study done by Haraguchi et. 
al. in 2000, bakuchiol proved to be effective in protecting mitochondrial functions by 
preventing lipid peroxidation in mitochondria and inhibiting oxygen consumption. It also 
protected the mitochondrial respiratory enzyme activities against peroxidation injury.13 
 In 2002, another study was conducted by Haraguchi and coworkers, and it was 
concluded that P. coryfolia contains phenolic compounds that exhibited effectiveness in 
protecting biological membranes against various oxidative stresses.14 In 2003, a study 
was conducted by Jiangning et. al. to determine the antioxidant effects of bakuchiol in 
lard. The double bond directly next to the phenol extends the conjugation of the molecule 
and this system helps to stabilize the free radical oxygen after the loss of the hydrogen.  
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The antioxidant activity of the molecule was found to have a protection factor (Pf) of 3.1 
at 0.02 % and 3.8 at 0.04 % in lard at 100 °C. It was suggested that the plant may be a 
good source of antioxidants if it were to be used as an additive in food.15 
 Another study conducted by Adhikkari et. al. in 2003 confirmed that bakuchiol is 
a potent antioxidant that inhibits the oxygen consumption of microsomes induced by lipid 
peroxidation and protects human red blood cells from rupturing (haemolysis).16  
 In 2005, a study was done by Jiangning et. al. to determine the anthelmintic 
activity of P. corylifolia seeds on flatworms and roundworms. It was found that 
radiolabeling bakuchiol greatly increased the uptake of bakuchiol by cells.17 Table 1 
shows the cell uptake of Iodine labeled bakuchiol in lymphoma cells at various 
concentrations while Table 2 shows the cell uptake of Iodine labeled bakuchiol in barcl-
95 cells at various concentrations. 
 
Table 1. Uptake Studies of 125I-bakuchiol in Lymphoma Cells (37 °C, 30 min) 
Concentration of I-bakuchiol (µM) 1.25 2.5 6.25 12.5 
% cell uptake 26.5 ± 1 39.5 ±1 40.5 ± 1 41 ± 2 
% Blank 2.4 ± .5 1.6 ± .4 1.1 ± .06 1.2 ± .04 
Mean ± SD, n=3     
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Table 2. Uptake Studies of 125I-bakuchiol in Barcl-95 Cells (37 °C, 30 min) 
Concentration of I-bakuchiol (µM) 1.25 2.5 6.25 12.5 
% cell uptake 17.6 ± .5 31.6 ± .4 26.4 ± .5 20.2 ± .6 
% Blank 0.9 ± .1 0.7 ± .4 1.4 ± .1 1.1 ± .3 
Mean ± SD, n=3     
 
 
Bakuchiol also exhibits antitumor properties in vitro. One study done by Park and 
coworkers in 2007 found that bakuchiol exhibits antitumor effects in rat livers by 
inducing apoptosis mitochondria in rat liver myofibroblasts.18 Another study done on 
human lung cells (alveolar adenocarcinoma cells) in 2010 by Chen and coworkers 
showed that bakuchiol induced apoptosis in the mitochondrial signaling pathway.19 
 Bakuchiol exhibits antibacterial activity20 notably against Staphylococcus aureus 
at only 2-4 µg/mL.21 In 2001, bakuchiol was tested as an antimicrobial agent against 
various oral microorganisms. It inhibited growth in no less than eleven various strains of 
Streptococcus tested in sucrose. It was determined that bakuchiol had potential for use in 
food additives and mouthwash in order to prevent and treat dental cavities. The 
development of bakuchiol as an antibacterial agent against oral pathogens had great 
potential.22 
 Bakuchiol has numerous other medical benefits. It exhibits weak anti-
inflammatory activity at 10 µM, but is toxic to cells at more than 30 µM.23 It performed 
as a beta-site APP cleaving enzyme-1 (BACE-1) inhibitor in vitro.24 It also exhibits 
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antimutagenic activity25 and hepatoprotective activity in human liver cells with a dose of 
only 1.0 µg/ml.26 It exhibited an antidiabetic affect in rats with type 2 diabetes without 
affecting lean rats. It reduced blood glucose and triglyceride levels.27 It has also been 
shown to be effective against breast cancer.28 
 Recently, a study was undertaken by Chaudhuri et. al. to determine the anti-aging 
effects that bakuchiol has and the results were compared to retinol (Vitamin A), a well 
known anti-aging agent used in many cosmetics. A 0.5 % solution of bakuchiol was 
applied topically twice a day to seventeen test subjects (females ages 40-65 years old) for 
twelve weeks. While bakuchiol is not structurally similar to retinol, it was found that they 
affect certain key anti aging genes and proteins the same way. Bakuchiol also has the 
advantage of being more photochemically and hydrolytically stable than retinol. These 
findings suggest that bakuchiol could become a key ingredient in dermatological and 
cosmetic products.29 
 Analogs of bakuchiol have also proven useful. One study done by Cha et. al. 
concluded that that some of its analogs were effective against tumor cells. One analog of 
bakuchiol (2) in particular (Figure 2) had an ED50 of 13.1 µM which, when compared to 
the ED50 of (+)-bakuchiol of 36.2 µM, exhibits more of an inhibitory effect on the 
proliferation of human tumor cells.30 While this is still considered inactive, other analogs 
of bakuchiol may be more potent. 
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Figure 2. Analog of Bakuchiol 
 
 
1.3 Previous Synthesis of Bakuchiol  
 Since its discovery in 1966, Bakuchiol has been synthesized using a number of 
different strategies. The medicinal properties and broad range of biological activity have 
made bakuchiol an attractive target for synthesis. The structure is small but contains a 
phenol, a vinyl group, and one quaternary center along the alkyl chain. The quaternary 
center has been the most challenging and also the main focus for most of the different 
synthetic pathways that have been established. The synthesis of bakuchiol has been done 
racemically and there have been multiple methods of installing the quaternary center. 
The first attempt at the synthesis of bakuchiol was done in 1967 by the Dev group 
and it resulted in bakuchiol methyl ester. It started by reacting geraniol (2) and ethyl vinyl 
ether (3) with mercuric acetate as shown in scheme 1 to yield compound 4 in 56 % yield.  
 
OH
O
O
Mercuric acetate
ethanol
56 %
+
2
3
4
 
 
Scheme 1. Geraniol and Ethyl Vinyl Ether 
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As shown in scheme 2, when 4 was heated at 182 ºC, aldehyde 5 was produced in 
90 % yield via a Claisen rearrangement. It is important to note that when 4 was heated at 
200 ºC, or aldehyde 5 was heated to 200 °C, alcohol 6 was formed via Ene reaction. 
Aldehyde 5 was then reacted with phenyl magnesium bromide 7 and dehydrated with 
alumina at 175 ºC to form the bakuchiol methyl ether (8).31 
 
 
Scheme 2. Claisen Rearrangement to Form Aldehyde then Bakuchiol Methyl Ether 
 
 
Only ten days later, the first total synthesis of racemic bakuchiol was received by 
another journal. This synthesis was done by the Miller group and also used geraniol (2). 
The geraniol was heated with p-methoxyacetophenone diethyl ketal (9) and mercuric 
acetate in diglyme at 160 ºC to form ketone 10 via Claisen rearrangement with a 50 % 
yield. This reaction is shown in scheme 3. 
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Scheme 3. Geraniol and P-methoxyacetophenone Diethyl Ketal to Form Ketone 10 
 
 
Ketone 10 was then reduced with sodium borohydride to form alcohol 11. The 
alcohol 11 was dehydrated by refluxing phosphorous oxychlorine in pyridine to form the 
methyl ether 8 in 76 % yield. The ether 8 was then demethylated by heating with 
methylmagnesium iodide at 175 ºC to form racemic bakuchiol (12) as shown in scheme 
4. 32 
O
O
10
O
HO
11
NaBH4
O
OH
MeMgI
P
O
ClCl
Cl
pyridine
175 C
812  
 
Scheme 4. Reduction, Dehydration and Demethylation to Form Racemic Bakuchiol 
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From 1967 to 1990, there were no new syntheses of bakuchiol. This was due to 
the difficulty of installing the quaternary center at the heart of the molecule. In 1990, the 
first enantioselective synthesis of 1 was performed by the Ogasawara group (Scheme 5). 
The synthesis started by treating the chiral starting material (S)-O-benzylglycol (13) with 
methyl lithiopropiolate in the presence of boron trifliuoride etherate to form 14 which 
was then cyclized to form δ-lactone 15.  The key step to form the chiral center of 
bakuchiol was for the δ-lactone 15 to react with vinylmagnesium bromide in the presence 
of copper (I) iodide which proceeded in a stereoselective fashion from the 
stereoelectronically favorable face of the molecule to give the δ-lactone 16 with a 
quaternary center. This is the quaternary center that makes up the heart of the bakuchiol 
molecule. The total synthesis of enantioenriched bakuchiol was completed by 
manipulating the molecule around the chiral center in a total of twelve steps with an 
overall yield of 16 %.33  This method required the purchase of chiral starting material to 
facilitate the establishment of the chiral quaternary center of bakuchiol. 
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Scheme 5. Ogasawara Method for Chiral Center Insertion 
 
 
In 1991, another method of synthesizing racemic bakuchiol in 3 steps was 
developed by Araki and Bustugan, utilizing organometallic chemistry. Geranylindium 
sesquibromide (17) was reacted with 2-(4-methoxyphenyl)acetaldehyde as shown in 
scheme 6 to form alcohol 18 in 85 % yield. The alcohol 18 was then mesylated with 
mesyl chloride-pyridine to form mesylate compound 19.  
Potassium tert-butoxide was used to treat the crude mesylate (19) and gave the 
methyl ether 8 with an overall yield of 66 %.  
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3In2Br3
OH
O
OMs
O
2-(4-methoxyphenyl)acetaldehyde
rt
85 %
17
18
MeSO2Cl
pyridine
97 %
(CH3)3COK
DMSO
80 C
80 %
O
8 19  
 
Scheme 6. Araki and Bustugan Synthesis of Racemic Bakuchiol Methyl Ester 
 
 
The mesylate 19 was sensitive to silica gel and would cyclize on a column. It was 
important to note from this synthesis the effects that the acidic conditions of silica gel 
column chromatography had on molecule 19, and that bakuchiol is an acid labile 
molecule. Upon treatment with acid, bakuchiol cyclizes to the p-meth-8-ene derivative 20 
(Figure 3).34 
 
 
Figure 3. Cyclized Bakuchiol 
 
 
In 1998, a new synthesis of (+)-bakuchiol (1) was developed by the Osaoka 
group. This method used a silyl group to direct stereoselective alkylation to construct the 
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chiral quaternary carbon center early in the synthetic pathway. Lithium diisopropylamide 
(LDA) followed by allyl bromide and LDA followed by methyl iodide were reacted with 
cyclohexenone 21 to yield cyclohexenone 22. Scheme 7 shows this chiral center being 
established in 22. After the chiral center was established, 22 was manipulated over a total 
of 16 steps to yield (+)-bakuchiol (1) with an overall yield of 5 %.35 This method required 
the purchase of a chiral starting material. The bulky silyl group acted as a chiral auxiliary 
to help set the desired stereochemistry in (+)-bakuchiol (1). 
 
 
 
Scheme 7. Stereoselective Addition to Form Quaternary Center 
 
 
 In 2008, (+)-bakuchiol (1) was synthesized by the Fukuyama group using 
vinylcopper(I) reagents. Chiral Michael acceptor 23 was added to the copper lithium 
reagent made from vinyl tin in a diastereoselective manner to create the quaternary 
carbon center in 24 (Scheme 8).  This method led to the total synthesis of (+)-bakuchiol 
with an overall yield of 20 % over ten steps.36 This method required the purchase of 
chiral phenyl oxazolidinone auxiliary to form 23 and 1.9 equivalents of toxic (vinyl)4Sn 
to set the desired stereochemistry. The asymmetric addition yielded the desired R 
enantiomer of 24 in a ratio of 95:5 with the less favored S enantiomer of 24 giving an 
enantiomeric excess (ee) of 90 %. 
13 
 
 
Scheme 8. Fukuyama Method of Establishing Chiral Center via Michael Addition 
 
 
 Independently, in 2008 the Li group synthesized (+)-bakuchiol (1) also in ten 
steps, with an increased yield of 51 %. This same group synthesized the non natural (R)-
enantiomer of bakuchiol in 9 steps with an overall yield of 40 %.37 The key steps in 
establishing the stereoselective center started off with geraniol (2) treated with Sharpless 
epoxidation reagents to form 25. The molecule was then protected with a TBS group to 
form 26 followed by a rearrangement of the silyl ether to form 27 (Scheme 9). This 
method was done using a racemic starting material and only required 13 mole percent (-)-
diisopropyl tartrate and only 5 mole percent Ti(OiPr)4. 
 
OH
OH
O
OTBS
O
CHO
OTBS
Ti(OiPr)4,
(-)-Diisopropyl tartrate
tBuOOH
DCM
94 %
tBuMe2SiCl,
TBSCL,
1H-imidazole
DMF
99 %
DCM
-78 °C
95 %
2 25
26
27
Al
OO
BrtBu
tBu
tBu
tBu
Br
 
Scheme 9. Li Method of Chiral Center Installation 
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In 2009, another method for the enantioselective synthesis of (+)-bakuchiol (1) 
was developed by the Novikov group using diazosulfonate C-H insertion to install the 
quaternary center. This method started with (–)-citronellol (28) as the starting material 
and was converted to δ-sulfone 31 in 3 steps with high yields. The total synthesis gave 1 
in 45 % yield over 10 steps, however, like many of the previous syntheses before it, it 
required the purchase of a chiral starting material. (Scheme 10) 
 
OH
(-)-citronellol (28)
O
S COOEt
O
S COOEt
N2O
S COOEt
Et3N
ClSO2CH2COOEt
95 %
DBU, MsN3
90 %
Rh2(esp)2
CH2Cl2
rt
85 %
29
3031
OO
OO
OO
 
Scheme 10. Novikov Preparation of δ-Sultine From (–)-Citronellol by C-H Insertion 
 
 
In 2010, the Hoveyda group was able to synthesize (+)-bakuchiol (1) in 3 steps 
with an overall yield of 72 %. This synthesis started with the phosphonation of geraniol 
(2) to yield alcohol 32. In another pot, a β-selective Ni catalyst was attached to the 
terminal end of an alkyne 26 followed by a hydroalumination. The two products were 
then mixed together with a bulky catalyst 28 and the reaction proceeded via the use of a 
NHC-Cu catalyzed Enantioselective Allylic Substitution (EAS).38 This efficient synthesis 
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 is shown in Scheme 11. While the yields were high, the NHC-Cu catalyst had to be  
 
prepared by another protocol that the Hoveyda group established.39  
 
 
N N
Ph
Ag
S
O
O
i-Pr
i-Pr
O
Ag
O
S
N
N
O
O
Ph
i-Pr
i-Pr
OH
OPO(OEt)2
O
O
Al(i-Bu)2
CIPO(OEt)2,
DMAP, Et3N
CH2Cl2, 22 C
3 mol % Ni(PPh3)2Cl2,
DIBALH, THF, 4 C
i. 1 mol % (35)
CuCl2 H2O
THF -15 C
ii. MeMgI, 180 C
2
32
33
34
Bulky NHC-Cu
Enantioselective Allylic Substitution (EAS)
Catalyst (35)
OH
1
 
Scheme 11. Hoveyda Synthesis of (+)-Bakuchiol via Ni Catalyzed NCH-Cu EAS 
 
 
In 2012, a synthetic route was developed by the Tadano group which utilized an 
asymmetric Claisen rearrangement. The Tadano group designed novel substrate 36, a β-
(allyloxy)acrylate derivative which was mixed with geraniol (2) and underwent a oxy-
Michael addition to form compound 37. Compound 37 was heated with butylated 
hydroxytoluene to yield enantiomers 38 and 39 via Claisen rearrangement with the set 
stereocenter (Scheme 12). Enantiomer 39 was the desired enantioenriched material for 
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the use of (+)-bakuchiol (1) synthesis. The overall synthesis was completed in 6 steps and 
gave a yield of 25 %.40 This method required the synthesis of the starting material 36 and 
only yielded 72 % of the desired enantioenriched quaternary center for the manipulation 
to (+)-bakuchiol (1). 
 
 
Scheme 12. Tadano Method for Asymmetric Claisen Rearrangement 
 
 
The most recent synthesis of (+)-bakuchiol (1) was done in 2013, once again by 
the Fukuyama group. A geranic acid 40 was treated with pivaloyl chloride and 
triethylamine, then (2'R)-2'-phenyloxazolidinone (41) was used as a chiral auxiliary to 
form compound 42. Compound 42 then underwent an asymmetric 1,4 addition to form 
compound 43 which was reacted with sodium hexamethyl disilazane (SHMDS), then p-
methoxy benzaldehyde (44). The product after 3 steps was enantioenriched bakuchiol 
methyl ether (45) which was then demethylated using the previously established method. 
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(+)-bakuchiol (1) was synthesized in four steps with an overall yield of 64 %.41 This 
synthesis shown in Scheme 13 was short and efficient but used (2'R)-2'-
phenyloxazolidinone as a chiral auxiliary.  
 
CO2H N
O
O
O
Ph
N
O
O
O
Ph
OMe
i. PivCl, Et3N, THF
-20 C
ii. LiCl
Et2O, -50 C
HN
O
O
Ph Cu(CN)Li22
i. HMDS, THF
-78 C
ii.
OHC
OMe
40 42
43
45
41
44  
Scheme 13. Fukuyama Method of Asymmetric 1,4 Addition 
 
 
1.4 Introduction to Desymmetrization 
 As shown above, (+)-bakuchiol (1) contains a chiral all carbon quaternary center. 
There have been multiple ways to set the stereocenter of (+)-bakuchiol (1). As shown in 
Scheme 14, an efficient and highly selective desymmetrization process was developed by 
the Petersen group that involves the reaction of a prochiral hydroxy diester 46, with a 
bulky chiral Brønsted acid 47, to form an enantioenriched γ-lactone (-)-48. 
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Scheme 14. Desymmetrization of Prochiral Hydroxy Diester 46 to Form Enantioenriched 
Lactone (-)-48 
 
 
This process is unique because of the acid's ability to selectively form an 
enatioenriched lactone from a prochiral substrate. This method of desymmetrization was 
able to produce (-)-48 with a 97 % yield and an enantiomeric excess (ee) of 98 %.42 This 
lactone will be used as the key intermediate to set the absolute configuration of the all 
carbon quaternary center in (+)-bakuchiol (1). 
1.5 Conclusion 
 There are multiple syntheses of (+)-bakuchiol (1) that have been published. Most  
of the previous work makes use of chiral starting materials either by purchasing or 
synthesizing them. Some methods required stoichiometric quantities of reagents to be 
used as chiral auxiliaries in order to form the chiral center. There also has not been a 
serious synthetic approach to develop a plethora of analogs. This work is focused on 
developing a synthetic pathway for racemic bakuchiol (12). After the synthetic pathway 
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has been refined, prochiral alcohol 46 will then be reacted with only 5 mole percent of 
commercially available chiral catalyst 47 to set the stereochemistry of the quaternary 
center. The use of the enantiomer of the phosphorous BINOL catalyst 47 could be used to 
synthesize the non-natural (–)-bakuchiol enantiomer. The final steps in the synthesis of 
(+)-bakuchiol (1) can then be manipulated to form various analogs using the developed 
pathway.
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CHAPTER II 
METHODOLOGY AND DEVELOPMENT OF THE SYNTHETIC PATHWAY 
 
 
2.1 Retrosynthesis 
 The most challenging aspect in the syntheses of the (+)-bakuchiol (1) has been the 
installation of the quaternary center. Historically, the enantioenrichment of a racemic 
molecule has been achieved with the use of chiral starting materials (purchased or 
synthesized). The use of expensive reagents as chiral auxiliaries in stoichiometric ratios 
has also been used to achieve enantioenrichment by some research groups. Recently, the 
Petersen group synthesized a chiral lactone (48) using only 5 mole percent of a chiral 
BINOL phosphoric acid catalyst (47).42 With this in mind, a retrosynthesis was designed 
around a quaternary center that had easily manipulated terminals. Scheme 15 shows the 
desired functional groups that would yield racemic bakuchiol (12).  
 
 
Scheme 15. Retrosynthesis of Racemic Bakuchiol 12
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The methyl group is set during the lactonization. The primary alcohols require separate 
protecting groups in order to manipulate them individually. The ester would be converted 
to an aldehyde which can undergo a Horner-Wadsworth-Emmons reaction to install the 
phenyl functional group. 
2.2 Results and Discussion 
 Our first step in the synthesis of racemic bakuchiol was the deprotonation of 
commercially available di-tert butyl malonate (50) using sodium hydride in THF. Methyl 
iodide was added and the reaction was quenched with aqueous ammonium chloride, 
producing the methyl malonate intermediate 51 with a 94 % yield. The methyl malonate 
intermediate 51 was again deprotonated with the use of NaH. Then, allyl bromide was 
added to install the allyl group. The reaction was then quenched with aqueous ammonium 
chloride to produce allyl methyl malonate intermediate 52 with a 94 % yield (Scheme 
16). 
 
 
Scheme 16. Methylation and Second Alkylation of Di Tert Butyl Malonate 
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To the allyl methyl malonate intermediate 52 was added a mixture of dioxane/ 
H2O, then 2,6-lutidine was added followed by OsO4 and sodium periodate to form 
aldehyde 53. The crude aldehyde intermediate 53 was dissolved in methanol and added to 
a sodium borohydride methanol solution. Prochiral hydroxy diester alcohol 46 was 
produced as a colorless oil with a 55 % yield. (Scheme 17) 
 
 
 
Scheme 17. Formation of the Prochiral Alcohol 
 
 
A new, more efficient synthesis of the prochiral diester alcohol 46 was refined for 
application.43 This route, shown in Scheme 18, involved the addition of 2-bromo ethyl 
acetate to methyl malonate 51 in THF at 0 °C and slowly bringing the reaction to room 
temperature. The acetate protecting group was then cleaved using potassium carbonate in 
methanol to yield hydroxyl diester 46 in 3 steps with an overall yield of 70 %. 
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Scheme 18. Formation of Prochiral Alcohol via More Efficient Pathway 
 
 
The next step produced racemic lactone 55 and is shown in Scheme 19. It 
required only 5 mole percent of para-toluene sulfonic acid. This is the step that would 
produce the enantioenriched lactone 48 using the chiral BINOL catalyst 47. However, for 
the racemic lactonization, p-toluenesulfonic acid was mixed with alcohol 46 in CH2Cl2 to 
yield lactone 55 in 84 % yield.  
 
 
Scheme 19. Racemic Lactonization of Prochiral Alcohol 
 
 
Racemic lactone 55 was added to LiAl(OtBu)3H and THF at -78 °C under argon. After 
18 hours, potassium sodium tartrate was used to quench the reaction and produce diol 49 
in 89 % yield. The selective protection of one terminal primary alcohol was required. In 
order to selectively protect one of the terminal alcohols, diol 49 was added to p-
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toluenesulfonic acid in CH2Cl2 to yield the hydroxy lactone 56 with a yield of 55 % as 
shown in scheme 20.  
 
 
 
Scheme 20. Reduction to Diol and Subsequent Lactonization to Hydroxy Lactone 
 
 
Once hydroxy lactone 56 was formed, a protecting group was required that would be 
readily added and easily cleaved. Many protecting groups were looked at but it was 
decided to use a bulky tert-butyl dimethyl silyl protection due to its ease of formation and 
relative size. As shown in scheme 21, hydroxy lactone 56 was mixed with imidazole and 
TBSCl in DMF to yield the desired TBS protected lactone 57 in 85 % yield.  
 
 
 
Scheme 21. Protection of Hydroxy Lactone with TBSCl 
 
 
The next step in the synthetic plan was to open the ring in a controlled manor that 
would yield an aldehyde, an ester, or an alcohol. The TBS lactone 57 was combined with 
a variety of reagents and bases in different solvents to form the desired alcohol. Scheme 
22 shows the reactions that were attempted with no success. First, 57 was refluxed with 
potassium carbonate in methanol in an attempt to form 58.  It was thought that the methyl 
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group may not be a suitable protecting group for the ester so the next attempt involved 
potassium carbonate in ethanol in an attempt to form 59. When no desired product was 
formed, it was thought that the base may not be strong enough, so 57 was added to 
potassium hydroxide in ethanol in an attempt to form 60. With still no desired product, 57 
was added to potassium carbonate in isopropanol in an attempt to form 61. Finally 57 was 
added to sodium hydroxide in water in an attempt to form 62. After this failed attempt, a 
new route was sought to open the ring.  
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Scheme 22. Attempted Ring Opening Reactions. 
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After these trials and failures, it was decided that there was too much functionality 
in the molecule and a protected alcohol was the more conservative approach. Scheme 23 
shows the TBS lactone 57 was reduced to lactol 63 using DIBALH in toluene at -78 °C, 
which allowed easier access to the ester carbon.  
 
 
Scheme 23. Reduction of TBS Lactone 57 to Lactol 63 
 
 
The TBS lactol 63 was then mixed with imidazole and TBSCl in DMF to test for the 
formation of an aldehyde. Gratifyingly, this yielded an aldehyde 64 but with two TBS 
groups that could not be manipulated independently. The aldehyde 64 was then used as a 
test substrate for the Horner-Wadsworth-Emmons reaction. It was combined with lithium 
hexamethyl disalizide and diethyl 4-methoxybenzylphosphonate in THF at -78 °C to 
form the desired HWE product 65 as shown in Scheme 24. 
 
 
Scheme 24. HWE of TBS Lactol 63 to Form HWE Product 65 
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With the Horner-Wadsworth-Emmons pathway set, a new protecting group was 
needed for the hydroxy lactone. This time, a methoxymethyl (MOM) protecting group 
was decided upon. The hydroxy lactone 56 was mixed with MOMCl and 
diisopropylethylamine in DCM at 0° C to yield a MOM protected lactone 66 in 99 % 
yield. The MOM lactone 66 was then reduced by adding it to DIBALH in toluene at -78 
°C to produce to a MOM lactol 67 in 98 % yield, as seen in Scheme 25. 
 
 
Scheme 25. Protection and Reduction of Hydroxy Lactone 56 
 
 
 Scheme 26 shows the ring opening of the MOM lactol 67 using imidazole and 
TBSCl in DMF at 60 °C to form the reactive aldehyde 68. Aldehyde 68 was then reacted 
with LiHMDS and diethyl-4-methoxybenzylphosphonate in THF at -78 °C to form the 
desired Horner-Wadsworth-Emmons product 69. 
 
 
Scheme 26. Ring Opening of MOM Lactol 67 and Subsequent HWE Reaction 
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The TBS group was then cleaved by using tetra-n-butylammonium fluoride 
(TBAF) in THF at 0 °C as shown in Scheme 27 to form alcohol 70 in a yield of 81 %. 
This alcohol can be manipulated later to form the desired vinyl group.  
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Scheme 27. Cleavage of TBS Group to Form Alcohol 70 
 
 
After the Horner-Wadsworth-Emmons reaction, two out of the four terminal ends 
were set in the pursuit of the racemic bakuchiol (12) synthesis. The next steps will 
involve an elimination of the alcohol to form a vinyl group followed by cleavage of the 
MOM protecting group in order to achieve the desired 
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CHAPTER III 
FUTURE WORK AND ANALOGS 
 
 
3.1 Background and Discussion of Proposed Pathway 
 In order to manipulate the alcohol 70, a tosyl group (good leaving group) will be 
added as seen in Scheme 28. The tosylate will then be eliminated with the use of 
potassium tert-butoxide, in order to form vinyl 72. Once the elimination has occurred, the 
MOM protecting group will be cleaved using HCl in methanol and water to yield the 
neopentyl alcohol 73 (Scheme 29).44 
 
 
Scheme 28. Addition of Tosyl Group to Alcohol 70 and Elimination to Vinyl 72
30 
 
 
Scheme 29. MOM Cleavage of 72 to Form Neopentyl Alcohol 73 
 
 
The neopentyl alcohol 73 will then need to be converted to alkyl chloride 74 by 
reacting it with cyanuric chloride and N,N-dimethyl formamide in methylene chloride 
(Scheme 30).45 
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Scheme 30. Conversion of Neopentyl 73 to Alkyl Chloride 74 
 
 
Once the alkyl chloride is formed, 74 can undergo a Grignard reaction with 
magnesium and 1-bromo-3-methyl-2-butene in anhydrous diethyl ether as shown in 
Scheme 31, in order to form the bakuchiol methyl ether (8).46 
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Scheme 31. Grignard Reaction of 74 to Form the Bakuchiol Methyl Ether (8) 
 
 
Once synthetic pathway to 8 has been established, demethylation could occur with 
the use of MeMgI as shown in the literature. Since this has been established, the synthesis 
of 1 using the Petersen desymmetrization process will be the next project. Once 1 has 
been synthesized using this method, a library of analogs can be synthesized by 
manipulating the Grignard reagent in Scheme 31.
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CHAPTER IV 
EXPERIMENTAL 
 
 
4.1 General Information 
All anhydrous reactions were performed with dry solvents in oven dried 
glassware under an argon atmosphere. Most solvents and reagents were obtained from 
commercial sources and used without further purification. THF, DCM, and TEA were 
freshly distilled. MeOH was distilled over CaCl. Toluene was distilled over P2O5. 
Chromatographic purification was performed using silica gel (60 Å, 32-63 μm). NMR 
spectra were recorded using a JEOL ECA spectrometer (500 MHz for 1H, 125 MHz for 
13C). Coupling constants, J, are reported in hertz (Hz) and multiplicities are listed as 
singlet (s), doublet (d), triplet (t), quartet (q), doublet of doublets (dd), triplet of triplets 
(tt), multiplet (m), etc. The reactions were monitored by TLC using silica G F254 
precoated plates. Flash chromatography was performed using flash grade silica gel 
(particle size: 40−63 μm, 230 × 400 mesh).
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4.2 Procedures 
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Scheme 32. Di-t-butyl 2-Methylmalonate (51) 
 
 
Di-t-butyl 2-methylmalonate (51): To a clean flame dried round bottom flask with a 
magnetic stir bar was added a solution of sodium hydride (60 % in mineral oil, .92 g, 
23.11 mmol) in THF (25 mL). Di-tert-butyl malonate (50) was added dropwise (5 mL, 
23.11 mmol) and the solution was stirred for 30 min at rt. To the reaction mixture was 
added iodomethane (1.48 mL, 23.11 mmol) dropwise and the solution was stirred for 3 h 
at rt. The reaction was quenched with saturated NH4Cl (10 mL) at 0 ºC, the phases were 
separated, the aqueous phase was extracted with EtOAc (3 x 20 mL). The combined 
organic phases were dried over MgSO4 and concentrated in vacuo. The residue was 
purified by flash chromatography on silica gel (10→30 % EtOAc in hexanes) to afford 
the di-tert-butyl 2-methylmalonate intermediate as a colorless oil (5.14 g, 97 % yield). 
The spectroscopic data matched the previously known compound reference.42 
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Scheme 33. Dialkylated Malonate Intermediate 54 
 
 
Dialkylated malonate intermediate 54: To a clean flame dried round bottom flask with 
stir bar was added a solution of sodium hydride (60 % in mineral oil, 4.47 g, 111.8 mmol 
in THF (75 mL) and di-tert-butyl 2-methylmalonate (51) was added dropwise (12.87 g, 
55.9 mmol) and the solution was stirred for 30 min at 0 ºC . To the reaction mixture was 
added 2-bromoethyl acetate (15.46 mL, 139.78 mmol) dropwise and the solution was 
stirred for 3 h and warmed to rt. The reaction was quenched with saturated NH4Cl (10 
mL) at 0 ºC, the phases were separated, the aqueous phase was extracted with EtOAc (3 x 
20 mL). The combined organic phases were dried over MgSO4 and concentrated in 
vacuo. The residue was purified by flash chromatography on silica gel (10→30 % EtOAc 
in hexanes) to afford the dialkylated malonate intermediate as a clear yellow oil (15.14 g, 
86 %).  
1H NMR (500 MHz, CDCl3) δ 4.21 (t, J = 5 Hz, 2H), 1.98 (t, J = 5 Hz, 2H), 1.93 (s, 3H), 
1.45 (s, 18H), 1.29 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3) δ 171.1, 168.3, 81.8, 62.1, 50.0, 33.9, 27.9, 21.0, 19.9 ppm. 
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Scheme 34. Hydroxy Diester 46 
 
 
Hydroxy Diester 46: To a clean flame dried round bottom flask with stir bar was added a 
solution of the dialkylated intermediate 54 (2.50 g, 16.46 mmol) in MeOH (25 mL) was 
added H2CO3 and the solution was stirred at rt for 45 min. The reaction mixture was 
diluted with CH2Cl and was extracted (3 x 30 mL) and H2O (1 x 30 mL). The organic 
layer was dried over MgSO4 and concentrated in vaccuo. The residue was purified via 
flash chromatography on silica gel (20→40 % EtOAc in hexanes with 0.1 % TEA) to 
afford the hydroxy diester (1.82 g, 84 % yield). The spectroscopic data matched the 
previously known compound reference.42 
 
 
Scheme 35. Racemic Lactone 55 
 
 
Racemic Lactone 55: To a clean flame dried round bottom flask with stir bar was added 
a solution of para-toluenesulfonic acid (0.07 g, .381 mmol) in CH2Cl2 (25 mL) at 0 ºC 
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was added the hydroxy diester 46 (2.09 g, 7.62 mmol). The solution was stirred for 27 h 
and allowed to warm to rt. The reaction was extracted using H2O (1 x 30 mL) and EtOAc 
(3 x 30 mL). The organic phases were dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash chromatography on silica gel (10- 30 % EtOAc in hexanes) 
to afford the racemic lactone (1.28 g, 84 % yield) as a clear colorless oil. The 
spectroscopic data matched the previously known compound reference.42 
 
 
Scheme 36. Diol 49 
 
 
Diol 49: To a clean flame dried round bottom flask with stir bar was added 
LiAl(OtBu)3H (5.93 g, 23.35 mmol) in THF (18 mL) was cooled to -78 ºC. A solution of 
the racemic lactone 55 (1.17 g, 5.83 mmol in THF, 7 mL) was cooled to -78 ºC and added 
to the mixture. It was allowed to react overnight and warm to rt. The reaction was 
quenched with saturated potassium sodium tartrate and HCl. The phases were separated 
with CH2Cl2 (1 x 20 mL) and EtOAc (2 x 20 mL). The organic phases were dried over 
MgSO4 and concentrated in vacuo to yield the diol as a clear colorless oil (1.04 g, 88 % 
yield). The spectroscopic data matched the previously known compound reference.42 
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Scheme 37. Hydroxy Lactone 56 
 
 
Hydroxy lactone 56: To a clean flame dried round bottom flask with stir bar was added a 
solution of para-toluenesulfonic acid (10 mg, 0.05 mmol) in CH2Cl2 (5 mL) at 0 ºC. Diol 
49 (221 mg, 1.08 mmol) was added dropwise. The solution was stirred overnight and 
allowed to warm to rt. The reaction was extracted using H2O (1 x 10 mL) and EtOAc (3 x 
10 mL). The organic phases were dried over MgSO4 and concentrated in vacuo. The 
residue was purified by flash chromatography on silica gel (10- 50 % EtOAc in hexanes) 
to afford the hydroxy lactone (165 mg, 55 % yield) as a clear colorless oil. The 
spectroscopic data matched the previously known compound reference.47 
 
 
Scheme 38. MOM Lactone 66 
 
 
MOM Lactone 66: To a clean flame dried round bottom flask with stir bar was added a 
solution of the hydroxy lactone 56 (77 mg, 0.59 mmol) in CH2Cl2 (12 mL) at 0 ºC. 
Diisopropylethylamine (0.15 mL, 1.5 eq) and MOMCl (0.13 mL, 3 eq) were added 
dropwise. The reaction was stirred for 4 h then diisopropylethylamine (0.15 mL, 1.5 eq) 
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and MOMCl (0.13 mL, 3 eq) were added. The reaction was stirred overnight and it was 
allowed to warm to rt. After, 14.5 h, diisopropylethylamine (0.15 mL, 1.5 eq) and 
MOMCl (0.13 mL, 3 eq) were added and the solution was allowed to stir for 24 h. The 
reaction was quenched with saturated sodium bicarbonate (10 mL). The organic phase 
was extracted with H2O (1 x 10 mL) and EtOAc (3 x 10 mL). The organic phases were 
dried over MgSO4 and concentrated in vacuo. The residue was purified by flash 
chromatography on silica gel (30 - 60 % EtOAc in hexanes) to afford the MOM protected 
hydroxy lactone (103 mg, 99 % yield) as a clear yellow oil. 
1H NMR (500 MHz, CDCl3) δ 4.60 (s, 2H), 4.31 (m, 2H), 3.68 (d, J = 5 Hz, 1H), 3.45 (d, 
J = 5 Hz, 1H), 3.33 (s, 3H), 2.51 (m, 1H), 2.05 (m, 1H), 1.22 (s, 3H) ppm. 
13C NMR (125 MHz, CDCl3) δ 180.7, 96.6, 72.2, 65.6, 55.5, 43.7, 32.5, 20.3 ppm. 
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Scheme 39. Lactol 67 
 
 
MOM protected lactol 67: To a clean flame dried round bottom flask with stir bar was 
added a solution of the MOM protected lactone 66 (493 mg, 2.83 mmol) in toluene (8 
mL) and the mixture was cooled to -78 ºC for 30 min. To this solution was added 
DIBALH (16.9 mL, 16.98 mmol) dropwise. This was allowed to react for 1 h. The 
reaction was quenched with H2O (1 mL), 15 % saturated NaOH (1 mL) and H2O (3 mL). 
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This solution was allowed to react for 1 h. The organic layer was dried over MgSO4 and 
concentrated in vacuo to yield the MOM protected lactol (0.49 g, 98 % yield).  
 
 
Scheme 40. Aldehyde 68 
 
 
Aldehyde intermediate 68: To a clean flame dried round bottom flask with stir bar was 
added MOM Lactol 67 (96 mg, 0.54 mmol) in DMF (5 mL). To this solution was added 
imidazole (370 mg, 5.45 mmol) and TBSCl (410 mg, 2.72 mmol). The mixture was 
allowed to react at room temperature for 2 minutes then placed in an oil bath at 70 °C and 
allowed to react overnight. The organic layer was separated with H2O and DCM, dried 
over MgSO4 and concentrated. The crude product was purified by flash chromatography 
in 0-15 % EtOAc in hexane to yield aldehyde 68 (111 mg, 70 %). 
1H NMR (500 MHz, CDCl3) δ 9.55 (s, 1H), 4.58 (s, 2H), 3.64 (m, 3H), 3.51 (d, J = 10 
Hz, 1H), 3.32 (s, 3H), 1.92 (m, 1H), 1.70 (m, 1H), 1.55 (s, 6H), 1.11 (s, 3H), 0.86 (s, 9H) 
ppm. 
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Scheme 41. Horner-Wadsworth-Emmons Product 69 
 
 
Horner-Wadsworth-Emmons Product 69: To a clean flame dried round bottom flask 
with stir bar was added diethyl 4-methoxybenzylphosphonate (0.21 mL, 1.22 mmol) and 
LiHMDS (1M in THF, 1.71 mL, 1.71 mmol) in THF (5 mL) at -78 °C. This solution was 
allowed to react for 30 min, then aldehyde 68 (198 mg, 0.68 mmol) was added and the 
mixture was allowed to react overnight. The reaction was quenched with saturated 
sodium bicarbonate (2 mL). The organic layer was separated with EtOAc, dried over 
MgSO4 and concentrated. The crude residue was purified by flash chromatography in 0 - 
30 % EtOAc in hexanes to yield 69 (100 mg, 37 %) as a clear colorless oil.  
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 10 Hz, 2H), 6.83 (d, J = 10 Hz, 2H), 6.29 (d, 
J = 15 Hz, 1H), 6.10 (d, J = 15 Hz, 1H), 4.62 (s, 2 H), 3.80 (s, 3H), 3.67 (t, J = 5 Hz, 2H), 
3.39 (s, 2H), 3.35 (s, 3H), 1.76 (dd, J = 10 Hz, 2H), 1.26 (s, 6H), 1.16 (s, 3H), 0.88 (s, 
9H) ppm. 
13C NMR (125 MHz, CDCl3) δ 158.9, 134.1, 130.6, 127.3, 127.4, 113.9, 96.8, 76.0, 60.1, 
55.3, 40.9, 29.8, 29.5, 26.0, 21.9, -5.2 ppm. 
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Scheme 42. Alcohol 70 
 
 
Alcohol 70: To a clean flame dried round bottom flask with stir bar was added the 
Horner-Wadsworth-Emmons product 69 (60 mg, 0.15 mmol) and 1.5 mL of THF. The 
solution was cooled to 0 °C for 40 min. TBAF (1 M in hexane, 0.31 mL, 0.31 mmol) was 
added and the mixture was allowed to react overnight. The mixture was diluted with 
EtOAc, washed w/ sodium bicarbonate and dried over MgSO4. The crude product was 
purified by flash chromatography in 10-100 % EtOAc in hexanes to yield the alcohol (35 
mg, 81 %). 
1H NMR (500 MHz, CDCl3) δ 7.28 (d, J = 10 Hz, 2H), 6.85 (d, J = 10 Hz, 2H), 6.32 (d, 
J = 15 Hz, 1H), 6.10 (d, J = 15 Hz, 1H), 4.64 (s, 2 H), 3.80 (s, 3H), 3.72 (t, J = 10 Hz, 
2H), 3.52 (m, 1H), 3.46 (d, J = 5 Hz, 1H), 3.42 (d, J = 5 Hz, 1H) 3.36 (s, 3H), 1.80 (m, J 
= 10 Hz, 2H), 1.17 (s, 3H) ppm. 
 
 
Scheme 43. Dialkyl Malonate 52 
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Allyl Diester 52: To a clean flame dried round bottom flask with stir bar was added NaH 
(60 %, 1.83 g, 45.92 mmol) and methyl malonate (5.28 g, 22.96 mmol) at 0 °C. To the 
reaction mixture was added 3-bromo-1-propene (4.99 mL, 57.40 mmol). The reaction 
was allowed to react for 3 h then quenched with NH4Cl at 0 °C. The organic layer was 
separated with EtOAc and dried over MgSO4. The crude product was purified by flash 
chromatography 0-20 % EtOAc in hexanes to yield the allyl malonate 52 (5.82 g, 94 %). 
The spectroscopic data matched the previously known compound reference.42 
 
 
Scheme 44. Aldehyde 53 
 
 
Malonate Aldehyde 53: To a clean flame dried round bottom flask with stir bar was 
added 7 mL of dioxane, 3 mL of deionized H2O and allyl malonate 52 (1.20 g, 4.47 
mmol). To the solution was added 2, 6 lutidine (1.04 mL, 8.94 mmol) followed by OsO4 
(2.5 %, 91 mL, .08 mmol) and NaIO4 (4.55 g, 17.88 mmol). The organic layer was 
flushed through filter paper and separated with DCM and H2O, then dried over sodium 
sulfate and concentrated in vaccuo to yield the crude malonate aldehyde 53 (1.35g). 
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Scheme 45. Alcohol 46 
 
 
Alcohol 46: To a clean flame dried round bottom flask with stir bar was added a solution 
of NaBH4 (.80 g, 21.24 mmol) in MeOH (20 mL) and cooled to 0 °C. To the solution was 
added aldehyde intermediate 53 (1.35 g, 5.31 mmol), and the mixture was allowed to 
react overnight. The reaction was quenched with 1 M HCl at 0 °C and the organic layer 
was extracted with DCM, dried over MgSO4 and concentrated in vacuo. The crude 
product was purified by flash chromatography in 20-60 % EtOAc in hexanes to yield 
prochiral alcohol 46 (.23g). The spectroscopic data matched the previously known 
compound reference.42  
 
 
Scheme 46. TBS Lactone 57 
 
 
Silyl Lactone 57: To a clean flame dried round bottom flask with stir bar was added 
imidazole (0.19 g, 2.87 mmol) and 5 mL of THF. To the solution was added lactone 56 
and the mixture was allowed to react for 22 h. The organic layer was rinsed with DCM (3 
x 20 mL) then separated with H2O and EtOAc. The organic layer was dried over MgSO4 
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and concentrated in vaccuo. The crude product was purified by flash chromatography in 
0-40 % EtOAc in hexanes to yield TBS lactone 57 (199 mg, 85 %). 
1H NMR (500 MHz, CDCl3) δ 4.26 (m, 2H), 3.78 (d, J = 10 Hz, 1H), 3.48 (d, J = 10 Hz, 
1H), 2.50 (m, 1H), 2.03 (m, 1H), 1.16 (s, 3H), 0.87 (s, 9H), 0.04 (s, 6H) ppm. 
 
 
Scheme 47. Attempted Formation of 60 
 
 
Ethyl Ester Alcohol 60: To a clean flame dried round bottom flask with stir bar was 
added silyl lactone 57 (38.2 mg, 0.15 mmol) with EtOH (5 mL) and KOH (8.77 mg, 0.15 
mmol). The mixture was allowed to react overnight. The organic layer was separated 
with EtOAc and H2O, dried over MgSO4 and concentrated. The crude product (50.2 mg) 
was analyzed with NMR. The desired product was not formed. 
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Scheme 48. Attempted Formation of 59 
 
 
Ethyl Ester Alcohol 59: To a clean flame dried round bottom flask with stir bar was 
added silyl lactone 57 (36.5 mg, 0.14 mmol) and MeOH (5 mL). To the solution was 
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added K2CO3 (3.7 mg, 0.02 mmol) and the mixture was refluxed 23 h. The solvent was 
removed under reduced pressure, and the residue was washed with H2O (3 x 10 mL), 
EtOAc (3 x 10 mL) and dried over MgSO4. The residue was concentrated to yield a crude 
residue (86.1 mg) which was analyzed with NMR. The desired product was not formed. 
 
 
Scheme 49. Attempted Formation of 61 
 
 
Isopropyl Ester Alcohol 61: To a clean flame dried round bottom flask with stir bar was 
added silyl lactone 57 and isopropyl alcohol (5 mL). To the solution was added K2CO3 (2 
mg, 0.01 mmol) and the mixture was refluxed for 13 h. The solvent was removed under 
reduced pressure and the residue was washed with H2O (3 x 10 mL), EtOAc (3 x 10 mL) 
and dried over MgSO4. The residue was concentrated to yield a crude residue (87 mg), 
which was analyzed with NMR. The desired product was not formed. 
 
 
Scheme 50. Formation of Lactol 63 
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Silyl Lactol 63: To a clean flame dried round bottom flask with stir bar was added dry 
toluene (10 mL) and silyl lactone 57 (100 mg, 0.40 mmol). The mixture was cooled to -
78 °C and DIBALH (0.45mL, 0.45 mmol) was added drop wise. The mixture was 
allowed to react for 1 h  then quenched with H2O (0.1mL), 10 % NaOH (0.1 mL), H2O2 
(0.2 mL) and allowed to react for 30 min. The organic layer was separated with diethyl 
ether (3 x 5 mL) dried over MgSO4 and concentrated to yield silyl lactol 63 (56 mg, 59 
%). 
 
 
Scheme 51. Attempted Formation of Alcohol 58 
 
 
Methyl Ester 58: To a clean flame dried round bottom flask with stir bar was added 
K2CO3 (67.9 mg, 0.49 mmol) and MeOH (10 mL). To the mixture was added silyl 
lactone 57 (100mg, 0.40 mmol). The mixture was refluxed overnight and separated with 
EtOAc (3 x 10mL) and H2O (10 mL). The organic layer was dried over MgSO4 and 
solvent was removed under reduced pressure. The crude product (30 mg) was analyzed 
via NMR. The desired product was not formed. 
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Scheme 52. Attempted Formation of Alcohol 62 
 
 
Alcohol 62: To a clean flame dried round bottom flask with stir bar was added silyl 
lactone 57 (47 mg, 0.19 mmol) in H2O (5 mL) and NaOH (106 mg, 2.65 mmol). The 
mixture was allowed to react for 2 h then quenched with HCl. The organic layer was 
separated with EtOAc (3 x 10mL) and H2O (10 mL), dried over MgSO4 and concentrated 
and analyzed by NMR. The desired product was not formed. 
 
 
 
Scheme 53. Formation of Aldehyde 64 
 
 
Silyl Aldehyde 64: To a clean flame dried round bottom flask with stir bar was added 
silyl lactol 63 (41 mg, 0.16 mmol) in DMF (5 mL) and imidazole (17.2 mg, 0.25 mmol). 
Tert-butyl silyl (38.07 mg, 0.25 mmol) was added and the mixture was allowed to react 
for 2 min, and then placed in an oil bath at 60 °C for 1 hr. Imidazole (11.5 mg, 0.16 
mmol) and tosyl chloride (13 mg, 0.08 mmol) were added and the mixture was allowed to 
react overnight. The organic layer was separated with DCM (3 x 10 mL) and H2O (3 x 10 
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mL), dried over MgSO4 and concentrate. The crude product was purified by flash 
chromatography in 0-30 % EtOAc in hexanes to yield silyl aldehyde 64 ( 29 mg, 48 % 
yield). 
1H NMR (500 MHz, CDCl3) δ 9.54 (s, 1H), 4.25 (m, 2H), 3.56 (d, J = 10 Hz, 1H), 3.48 
(d, J = 10 Hz, 1H), 2.50 (m, 2H), 1.60 (s, 3H), 0.88 (s, 18 H), 0.04 (s, 12H) ppm. 
 
 
Scheme 54. Formation of 65 
 
 
Silyl Phenol 65: To a clean flame dried round bottom flask with stir bar was added 
LiHMDS (1M in THF/ethyl benzene, 0.24 mL, 0.24 mmol) in THF (3 mL) and diethyl 4-
methoxybenzylphosphonate (62.3 mL, 0.24 mmol). The mixture was cooled -78 °C and 
silyl aldehyde 64 (29 mg, 0.08 mmol) was added. After 3 h, the reaction was quenched 
with NH4Cl at 0 °C. The organic layer was separated with EtOAc (3 x 10 mL), dried over 
MgSO4, and concentrated. The crude residue was columned in 0-100 % EtOAc in 
hexanes to yield silyl phenol 65 (18.8 mg, 50 %). 
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APPENDIX A 
NMR SPECTRA OF COMPOUNDS 
 
 
NMR spectra were recorded using a JEOL ECA spectrometer (500 MHz for 1H, 
125 MHz for 13C). All spectra were taken at room temperature in CDCl3. 
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13C NMR of 54 
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1H NMR of 66 
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13C NMR of 66 
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1H NMR of 68 
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1H NMR of 69 
ATS-2-99-H-DRY-1.JDF
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1H NMR of 70 
ATS-HWE-OH-H-1-INTEGRATED.ESP
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1H NMR of 47 
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1H NMR of 64 
ATS-1-275-5-H-1.JDF
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